Keenova TERLIVAZ Real-World Data Advances HRS-AKI Care
Dublin, Ireland | May 1, 2026 Keenova Therapeutics has announced new real-world clinical analysis of TERLIVAZ® (terlipressin) for hepatorenal...
Real-World Evidence
Advertisement
Neurelis Shows Strong Seizure Control Data for VALTOCO at AAN
SAN DIEGO, Calif., April 16, 2026 Neurelis, Inc. has announced new clinical and real-world analyses demonstrating the effectiveness of...
Revolution Medicines Reports Phase 3 Survival Gain PDAC
REDWOOD CITY, CALIFORNIA, USA, April 13, 2026 Revolution Medicines has announced positive topline results from its pivotal Phase 3...
Bristol Myers Squibb Reports New Camzyos Data at ACC
PRINCETON, NEW JERSEY, March 23, 2026 Bristol Myers Squibb has unveiled new clinical and real-world data for Camzyos (mavacamten)...
AI Healthcare Intelligence Tech Advances Clinical Research
RESEARCH TRIANGLE PARK, N.C., February 20, 2026 — IQVIA announced continued expansion of its healthcare intelligence and advanced analytics...
Advertisements
RSV Vaccine Data Show Reduced Cardio-Respiratory Risks
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
GLP-1 Therapy Linked to Reduced Asthma Exacerbations
MILWAUKEE, Feb. 15, 2026 — New research presented by the American Academy of Allergy, Asthma & Immunology (AAAAI) reveals...
MIPLYFFA Real-World Data Strengthen NPC Treatment Impact
CELEBRATION, Fla., Feb. 4, 2026 —Zevra Therapeutics announced the presentation of positive new real-world data on MIPLYFFA® (arimoclomol) in...
Red Nucleus Acquires Bridge to Strengthen HEOR Expertise
BOSTON, Feb. 2, 2026 — Red Nucleus, a global strategic partner to pharmaceutical and biotechnology companies, announced a definitive...
Johnson & Johnson Launches CORE-VA Registry to Advance Arrhythmia Care
IRVINE, Calif., October 10, 2025 — Johnson & Johnson MedTech has announced the launch of the CORE-VA (Catheter-based Outcomes...
Advertisement
